. 2024 Apr 19;49(1):60–69. doi: 10.5114/ceji.2024.136512
Copyright: © 2024 Polish Society of Experimental and Clinical Immunology
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Fig. 3.
Classification of hypereosinophilic syndromes (HES) – ICOG-EO 2011